SCHEMBL8904637

SCHEMBL8904637

C[CH]OC(=O)CCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.61
ALDH1A1 P00352 2/20 0.55
KEAP1 Q14145 1/20 0.53
KMT2A Q03164 2/20 0.51
FFAR1 O14842 1/20 0.50
TRPV1 Q8NER1 1/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GPR52 Q9Y2T5 1/20 0.46
ALOX5 P09917 1/20 0.46
HDAC3 O15379 1/20 0.46
MAPK1 P28482 1/20 0.46
ADRA1A P35348 1/20 0.46
HDAC4 P56524 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14952781 0.83 TDP1 (0.63) TDP1ALDH1A1KEAP1KMT2AFFAR1
SCHEMBL347597 0.81 TDP1 (0.61) TDP1ALDH1A1KEAP1KMT2AFFAR1
SCHEMBL27428759 0.81 TDP1 (0.61) TDP1ALDH1A1KEAP1KMT2AFFAR1
SCHEMBL705231 0.81 TSHR (0.56) ALDH1A1KMT2AHDAC8HDAC6KDM4E
Acetic Acid SCHEMBL27752250 0.81 TDP1 (0.56) TDP1ALDH1A1KEAP1KMT2AFFAR1
SCHEMBL4642125 0.79 TDP1 (0.58) TDP1ALDH1A1KEAP1KMT2AFFAR1
Methyl 3-Phenylpropanoate SCHEMBL168711 0.79 TDP1 (0.68) TDP1ALDH1A1KEAP1KMT2AFFAR1
SCHEMBL29086538 0.78 TDP1 (0.73) TDP1ALDH1A1KEAP1KMT2AFFAR1
SCHEMBL1739439 0.78 TDP1 (0.73) TDP1ALDH1A1KEAP1KMT2AFFAR1
Ethyl 3-Phenylpropanoate SCHEMBL6847259 0.77 TDP1 (0.66) TDP1ALDH1A1TRPV1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020032080-A1 COMPOUND, SALT OF COMPOUND, NEUROMODULATION AGENT, METHOD FOR EVALUATING NEUROMODULATION AGENT, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING SALT OF COMPOUND 学校法人慶應義塾 2020-02-13 WO disclosed
US-5633243-A Anti-tumor platinum complexes, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1997-05-27 US disclosed
US-5527905-A RELATIVELY FEW SIDE EFFECTS, GOOD SOLUBILITY IN WATER SANKYO COMPANY, LIMITED (JP) 1996-06-18 US disclosed
EP-0290280-B1 Anti-tumor platinum complexes, their preparation and their therapeutic use SANKYO CO (JP) 1994-01-19 EP disclosed
CN-1017803-B ANTI-TUMOR PLATINUM COMPLEX AND PREPARATION THEREOF SANKYO CO (JP) 1992-08-12 CN disclosed
CN-1034544-A Antineoplastic platinum complex, its preparation and therepic use SANKYO CO (JP) 1989-08-09 CN disclosed
EP-0290280-A2 Anti-tumor platinum complexes, their preparation and their therapeutic use Sankyo Company Limited (JP) 1988-11-09 EP disclosed